Organigram (TSE:OGI) Shares Up 0.4%

Shares of Organigram Holdings Inc. (TSE:OGI) shot up 0.4% on Friday . The stock traded as high as C$2.65 and last traded at C$2.57. 280,992 shares changed hands during trading, a decline of 29% from the average session volume of 396,228 shares. The stock had previously closed at C$2.56.

Analyst Ratings Changes

Several brokerages recently weighed in on OGI. Alliance Global Partners raised their target price on Organigram from C$2.00 to C$2.70 and gave the company a “neutral” rating in a research note on Wednesday, February 14th. Jefferies Financial Group decreased their price target on Organigram from C$4.95 to C$4.40 and set a “buy” rating for the company in a research report on Tuesday, February 27th. Finally, ATB Capital set a C$5.25 price target on Organigram and gave the company an “outperform” rating in a research report on Wednesday, April 3rd.

Organigram Stock Performance

The firm has a 50 day moving average of C$2.83 and a 200-day moving average of C$2.24. The stock has a market capitalization of C$241.84 million, a PE ratio of -1.02, a P/E/G ratio of 0.42 and a beta of 1.11. The company has a debt-to-equity ratio of 1.75, a quick ratio of 2.62 and a current ratio of 6.95.

Organigram (TSE:OGI) last announced its quarterly earnings data on Tuesday, February 13th. The company reported C($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.13) by C($0.06). The business had revenue of C$36.46 million during the quarter, compared to analysts’ expectations of C$38.13 million. Organigram had a negative return on equity of 54.53% and a negative net margin of 153.80%. Research analysts forecast that Organigram Holdings Inc. will post 0.09216 earnings per share for the current year.

Insider Transactions at Organigram

In other news, Director Donald Geoffrey Machum sold 23,000 shares of the firm’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of C$2.74, for a total transaction of C$62,964.80. Company insiders own 34.74% of the company’s stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.